Product Overview
Dermacell is a decellularized regenerative human tissue matrix allograft processed using proprietary MATRACELL® technology from LifeNet Health.
DermACELL is sterile and ≥97% donor DNA free
•Sterility assurance level (SAL) 10-6 and ready to use - no rinsing required.
•Dermacell is decellularized using Matracell, a proprietary and patented technology that removes at least 97% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2
•After being rendered acellular, Dermacell undergoes a terminal sterilization step to ensure a Sterility Assurance Level (SAL) of 10-6.
•Low-dose gamma irradiation performed at ultra-low temperatures is used to reach surgical device-grade sterility, which lowers the probability of an active organism in the graft to 1 in 1,000,000.2
Sterile
•Sterility assurance level (SAL) 10-6.2
Ready to use (RTU)
•No rinsing required.2
•â‰¥97% Donor DNA-Free
•A proprietary and patented technology that removes at least 87% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2
Operative benefits
•Dermacell provides a medical device-grade sterility assurance level of 10-6 and requires no rinsing prior to application.2 The graft features a wide suture border to further support intraoperative placement. (https://www.stryker.com/us/en/index.html)
